This study tested a new COVID-19 vaccine called GEO-CM04S1 to see if it is safe and can trigger a protective immune response. It involved 119 healthy adult volunteers. The research aimed to find the best dose and see how well the vaccine works when given as a first course or as a…
Phase: PHASE1, PHASE2 • Sponsor: GeoVax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:43 UTC